Three pending Bay Area biotech IPOs and follow-on offerings from four other drug makers could collectively raise more than $1.1 billion, highlighting biotech's latest Wall Street resurgence amid hope for new cancer treatments and drugs and vaccines.....»»

The run of biotech IPOs from the Bay Area continues, with two new filings on Thursday and a third setting a price range that day. There are now five local IPOs waiting in the wings from the life science sector that has already produced six IPOs in the.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although the market remains bubbly, some of the newe.....»»

"It's definitely not best of breed, but it's not garbage either," the "Mad Money" host said......»»

"It's definitely not best of breed, but it's not garbage either," the "Mad Money" host said......»»

H.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) read more.....»»

Apple Inc. (NASDAQ: AAPL) is giving cash-strapped consumers a reason to buy its products. read more.....»»

In the last week, a gene therapy company announced plans for a $100M IPO, a Waltham biopharma was acquired for upwards of $2.1 billion and announced collaborations......»»

Data mining firm Palantir Technologies Inc is aiming to file confidentially with U.S. regulators to go public in the coming weeks, emboldened by the strong performance of other initial public offerings (IPOs), people familiar with the matter said......»»

Nasdaq Initial public offerings have surged since March, when the broader market began to recover from the coronavirus-induced rout, according to Bespoke .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

The first of the two IPOs is expected on Wednesday and the second on Friday. They would be the fourth and fifth life science debuts on Wall Street from the region this year......»»

Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, clinical readouts, ASCO presentations and a few FDA approvals. read more.....»»

Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, clinical readouts, ASCO presentations and a few FDA approvals. Arca Biopharma Inc (.....»»

IPOs are rare right now, but coffee maker JDE Peet's saw its Friday offer snapped up by investors. Julian Satterthwaite reports......»»

Nasdaq's new curbs on Chinese IPOs represent the latest flashpoint in the financial relationship between the world's two largest economies.....»»

Nasdaq Imposes Restrictions On Chinese IPOs, Halting Futures Rally Tyler Durden Mon, 05/18/2020 - 21:00 In a move that anyone who has ever invested in a Chinese fraud sto.....»»

Nasdaq Inc is set to unveil new restrictions on initial public offerings (IPOs), a move that will make it more difficult for some Chinese companies to debut on its stock exchange, people familiar with the matter said on Monday......»»